Tulio Rodriguez, M.D., joined City of Hope^® Cancer Center in Zion, Illinois in September 2023 as the director of the Hematology, Bone Marrow Transplant and Cellular Therapy Program and a hematologic oncologist, where he specializes in the treatment of blood cancers such as lymphoma, leukemia and myeloma. He cares for patients at the City of Hope Cancer Care Downtown Chicago location as well as the Chicago-area hospital, located in Zion, Illinois. Board certified in hematology by the American Board of Internal Medicine and bilingual in English and Spanish, Dr. Rodriguez brings with him over 20 years of experience in hematologic malignancies and bone marrow transplantation and has performed over 2,500 transplant procedures during his career.

After earning his medical degree from Pontificia Universidad Católica Madre y Maestra School of Medicine in Santiago, Dominican Republic, Dr. Rodriguez did his internal medicine residency at San Juan Veterans Affairs Medical Center in San Juan, Puerto Rico, then completed fellowships in hematology/oncology and bone marrow transplantation at the University of Texas Health Science Center in San Antonio, Texas.

In addition to practicing at City of Hope, Dr. Rodriguez serves as the Clinical Professor for the Department of Hematology & Hematopoietic Cell Transplantation and is also a professor of medicine at Rosalind Franklin University of Medicine and Science in Chicago.

Dr. Rodriguez has an extensive research background, regularly serving as a guest lecturer on innovations in hematology, earning numerous awards for his research, including the Leukemia Research Foundation’s Hero of Hope Award and the American Cancer Society’s Clinical Oncology Fellowship Award.

Locations

Chicago Cancer Center

2520 Elisha Avenue
Zion, IL 60099

Phone Numbers

Downtown Chicago Cancer Care

160 Upper E. Illinois St.
Chicago, IL 60611

Phone Numbers

Education & Experience

Board Certification

American Board of Internal Medicine (ABIM)

Degree

Pontificia Universidad Católica Madre y Maestra School of Medicine, Santiago, Dominican Republic

Residency

Internal Medicine, San Juan Veterans Affairs Medical Center, San Juan, Puerto Rico

Fellowships

Hematology/Oncology, University of Texas Health Science Center, San Antonio, Texas
Bone Marrow Transplantation, The University of Texas Health Science Center at San Antonio, San Antonio, Texas

Awards

2012, Hero of Hope Award, Leukemia Research Foundation, Chicago, Illinois
1995, American Cancer Society Clinical Oncology Fellowship Award, University of Texas, Health Science Center, San Antonio, Texas.
1995, National Research Service Award, National Cancer Institute, University of Texas, Health Science Center, San Antonio, Texas.
1994, National Research Service Award, National Cancer Institute, University of Texas, Health Science Center, San Antonio, Texas.

Publications

Shaughnessy, P. J., Ornstein, D., Ririe, D., Callander, N., Anderson, J. E., Pollack, M.S., Freytes, C. O., J. Cruz. Rodriguez T, Bachier, C., LeMaistre, C. F., Phase 2 study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experience. Biol Blood Marrow Transplant. 2002;8(8):420-8.
Rodriguez TE, Stiff PJ. Current treatment results of allogeneic bone marrow transplantation for acute myeloid and lymphoid leukemia. Curr Hematol Rep. 2003 Jul;2(4):295-30I. Review Article
Toor, AA.; Ayers, J; Strupeck, J; Parthasarathy, M; Creech, S: Rodriguez, T.; Stiff, P. J. Favourable results with a single autologous stem cell transplant following conditioning with busulphan and cyclophosphamide in patients with multiple myeloma. Br J Haematol. 2004;124(6):769-76.
Duns JE, Stiff PJ, Choi J, Parthasarathy M. Rodriguez T, Toor AA. Second allografts for relapsed hematologic malignancies: feasibility of using a different donor. Bone Marrow Transplant. 2005 Feb;35(3):26 l-4.
Stiff, PJ, Miller, L. A., Mumby, P., Kiley, K, Batiste, R., Porter, N., Potocki, K., Volle, M., Lichtenstein, S., Wojtowicz, S., Zakrzewski, S., Toor, A0 Rodriguez, T, Patients' understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation. Bone Marrow Transplant. 2006; 1-6. January 23rd.
Stiff P, Mumby P, Miler L, Rodriguez T, Parthswarthy M, Kiley K, Porter N, Batiste R, Wojtowitz S, Lichtenstein S, Fox-Geiman M, Toor A. Autologous Hematopoietic Stem Cell Transplants that Utilize Total Body Irradiation Can Safely be Carried Out Entirely on an Outpatient Basis. Bone Marrow Transplant. 2006 Dec; 38(11):757-64.
Smith, S. E., Toor, A., Rodriguez. T., Stiff, P. The administration of polymerized human hemoglobin (Pyridoxylated) to a Jehovah's Witness after submyeloablative stem cell transplantation complicated by delayed graft failure. Compr Ther. 2006 Fall;32(3 ):172-5.
Fung HC, Stiff P, Schriber J, Toor A, Smith E, Rodriguez T, Krishnan A, Molina A, Smith D, Ivers B, Kogut N, Popplewell L, Rodriguez R, Somlo G, Forman SJ, Nademanee A. Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphoma. Biol Blood Marrow Transplant. 2007May;13(5):594-600. Epub 2007 Mar 23
Toor, AA, Stiff, PJ, Nickoloff, BJ. Rodriguez T., Klein, J., Gordon, K.B. Alefacept in corticosteroid refractory graft versus host disease: early results indicate promising activity, J Dermatolog Treat. 2007;18(1):13-8.
Mullane, K., Toor, A. A., Kalnicky, C. Rodriguez T., Klein, J., Stiff, P. Posaconazole Salvage Therapy Allows Successful Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory Invasive Mold Infections. Transpl Infect Dis. 2007 Jun;9(2):89-96.